Corrections
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
BMJ 2022; 376 doi: https://doi.org/10.1136/bmj.o109 (Published 18 January 2022) Cite this as: BMJ 2022;376:o109
This paper by Palmer and colleagues (BMJ 2021;372:m4573, doi:10.1136/bmj.m4573, published 13 January 2021) has been corrected to account for an error in the data for all cause death extracted from the DECLARE-TIMI-58 trial. When the correct data for the DECLARE-TIMI-58 trial are used, the network estimated …